Hypaque Injection and Sandostatin LAR
Determining the interaction of Hypaque Injection and Sandostatin LAR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diatrizoate
Brand name: Cystografin, Cystografin-Dilute, Gastrografin, MD-76 R, MD-Gastroview
Synonyms: Diatrizoate Meglumine
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Octreotide (injection), Octreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hypaque Injection-Sandostatin LAR Depot
- Hypaque Injection-Sandostatin LAR Depot injection
- Hypaque Injection-Sani-Supp
- Hypaque Injection-Sani-Supp rectal
- Hypaque Injection-Sansert
- Hypaque Injection-Santyl
- Sandostatin LAR-Hypaque Meglumine
- Sandostatin LAR-Hypaque-76
- Sandostatin LAR-Hypaque-Cysto
- Sandostatin LAR-Hyper-Sal inhalation
- Sandostatin LAR-Hyperhep B
- Sandostatin LAR-HyperHEP B S/D